secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001628280-26-026905
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor names Ludovic Brellier EVP Bioscience & Medtech Products; Gourdier to depart by Dec 2026
--------------------------------------------------------------------------------

- Ludovic Brellier appointed EVP, Bioscience & Medtech Products and Chief Transformation Officer effective May 1, 2026.
- Brellier joins from Danaher, where he was President of Cytiva’s Hardware Solutions; will lead Revival Management Office.
- Current EVP Benoit Gourdier will transition to a support role and depart Avantor no later than December 31, 2026.
- Brellier to oversee BMP business growth, operational performance, and enterprise transformation initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/0001628280-26-026905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/avtr-20260417.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-026905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer